Modified animal erythropoietin polypeptides and their uses

Details for Australian Patent Application No. 2009296397 (hide)

Owner Eli Lilly and Company Ambrx Inc.

Inventors Tian, Feng; Hays Putnam, Anna-Maria A.; Song, Frank; Chu, Stephanie; Sheffer, Joseph; Barnett, Richard S.; Siladi, Marc; Atkinson, Kyle; Lee, Darin; Canning, Peter C.

Agent FB Rice

Pub. Number AU-A-2009296397

PCT Pub. Number WO2010/036964

Priority 61/100,692 26.09.08 US; 61/100,679 26.09.08 US

Filing date 25 September 2009

Wipo publication date 1 April 2010

International Classifications

C07K 14/505 (2006.01) Peptides having more than 20 amino acids

C07H 21/00 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 1/113 (2006.01) General processes for the preparation of peptides

Event Publications

12 May 2011 PCT application entered the National Phase

  PCT publication WO2010/036964 Priority application(s): WO2010/036964

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009296404-Formliner and method of use

2009296396-Organic tandem solar cells